Immunogenicity 12414
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
TNFAIP2
Transcript ID
uc001ymm.1
HLA INFO
A*02:01
TCR INFO
No TCR info found!
Full length protein sequence (654 aa)
MSEAS
1
SEDLV
6
PPLEA
11
GAAPY
16
REEEE
21
AAKKK
26
KEKKK
31
KSKGL
36
ANVFC
41
VFTKG
46
KKKKG
51
QPSSA
56
EPEDA
61
AGSRQ
66
GLDGP
71
PPTVE
76
ELKAA
81
LERGQ
86
LEAAR
91
PLLAL
96
ERELA
101
AAAAA
106
GGVSE
111
EELVR
116
RQSKV
121
EALYE
126
LLRDQ
131
VLGVL
136
RRPLE
141
APPER
146
LRQAL
151
AVVAE
156
QERED
161
RQAAA
166
AGPGT
171
SGLAA
176
TRPRR
181
WLQLW
186
RRGVA
191
EAAEE
196
RMGQR
201
PAAGA
206
EVPES
211
VFLHL
216
GRTMK
221
EDLEA
226
VVERL
231
KPLFP
236
AEFGV
241
VAAYA
246
ESYHQ
251
HFAAH
256
LAAVA
261
QFELC
266
ERDTY
271
MLLLW
276
VQNLY
281
PNDII
286
NSPKL
291
VGELQ
296
GMGLG
301
SLLPP
306
RQIRL
311
LEATF
316
LSSEA
321
ANVRE
326
LMDRA
331
LELEA
336
RRWAE
341
DVPPQ
346
RLDGH
351
CHSEL
356
AIDII
361
QITSQ
366
AQAKA
371
ESITL
376
DLGSQ
381
IKRVL
386
LVELP
391
AFLRS
396
YQRAF
401
NEFLE
406
RGKQL
411
TNYRA
416
NVIAN
421
INNCL
426
SFRMS
431
MEQNW
436
QVPQD
441
TLSLL
446
LGPLG
451
ELKSH
456
GFDTL
461
LQNLH
466
EDLKP
471
LFKRF
476
THTRW
481
AAPVE
486
TLENI
491
IATVD
496
TRLPE
501
FSELQ
506
GCFRE
511
ELMEA
516
LHLHL
521
VKEYI
526
IQLSK
531
GRLVL
536
KTAEQ
541
QQQLA
546
GYILA
551
NADTI
556
QHFCT
561
QHGSP
566
ATWLQ
571
PALPT
576
LAEII
581
RLQDP
586
SAIKI
591
EVATY
596
ATCYP
601
DFSKG
606
HLSAI
611
LAIKG
616
NLSNS
621
EVKRI
626
RSILD
631
VSMGA
636
QEPSR
641
PLFSL
646
IKVG
651
Mutation Information
DNA mutation:
None
Peptide Range:
12 ~ 36
Mut AA position:
24 (13 in Wild Type peptide)
Alignment
Wild Type:
"PLEAGAAPYREEEEAAKKKKEKKKK
||||||||||||.||||||||||||
Mutant:
PLEAGAAPYREEKEAAKKKKEKKKK"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) TNFAIP2
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay